{
    "clinical_study": {
        "@rank": "38723", 
        "arm_group": {
            "arm_group_label": "treatment", 
            "arm_group_type": "Experimental", 
            "description": "Fenretinide 200 mg PO days 1-25, q 28 days x 6 cycles."
        }, 
        "brief_summary": {
            "textblock": "RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the\n      development or recurrence of cancer. The use of fenretinide may be an effective way to\n      prevent the development of cancer in patients with neoplasia of the mouth.\n\n      PURPOSE: Phase II trial to study the effectiveness of fenretinide in preventing cancer in\n      patients who have neoplasia of the mouth."
        }, 
        "brief_title": "SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth", 
        "completion_date": {
            "#text": "March 2000", 
            "@type": "Actual"
        }, 
        "condition": "Head and Neck Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Head and Neck Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Evaluate the efficacy of fenretinide in patients with oral intraepithelial\n      neoplasia. II. Assess the toxicity of fenretinide in these patients.\n\n      OUTLINE: Patients receive oral fenretinide on days 1-25 every 28 days for a maximum of 6\n      courses. After 6 courses, patients receive a post-treatment biopsy. Patients exhibiting\n      disease progression or unacceptable toxicities are removed from the study. Patients are\n      followed at 3 and 6 months.\n\n      PROJECTED ACCRUAL: A total of 51 patients will be accrued."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically proven oral mucosal intraepithelial neoplasia\n        Stage II: moderate dysplasia, keratosis with atypia Stage III: severe keratinizing or\n        nonkeratinizing dysplasia No myelodysplastic syndrome No retinopathies\n\n        PATIENT CHARACTERISTICS: See General Eligibility Criteria\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: No concurrent biologic therapy Chemotherapy:\n        No concurrent chemotherapy Endocrine therapy: No concurrent endocrine therapy\n        Radiotherapy: No concurrent radiotherapy Surgery: Prior surgical ablation of prior\n        dysplastic sites allowed Other: At least 2 months since prior therapy toxicities Patient\n        Characteristics-- Age: Not specified Performance Status: SWOG 0-1 Life Expectancy: Not\n        specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other:\n        Not pregnant or nursing Negative pregnancy test Fertile patients must use effective\n        contraception at least 1 month before, during, and at least 2 months after study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "5", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003223", 
            "org_study_id": "CDR0000066085", 
            "secondary_id": [
                "SWOG-9507", 
                "U10CA037429"
            ]
        }, 
        "intervention": {
            "arm_group_label": "treatment", 
            "description": "200 mg/day PO, days 1-25 q 28 days x 6 cycles.", 
            "intervention_name": "fenretinide", 
            "intervention_type": "Drug", 
            "other_name": "N-(4-hydroxyphenyl)retinamide, 4-HPR"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Retinamide", 
                "Fenretinide"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "lip and oral cavity cancer", 
        "lastchanged_date": "July 20, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85724"
                    }, 
                    "name": "Arizona Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85723"
                    }, 
                    "name": "Veterans Affairs Medical Center - Tucson"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66160-7357"
                    }, 
                    "name": "University of Kansas Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40536-0084"
                    }, 
                    "name": "Albert B. Chandler Medical Center, University of Kentucky"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40511-1093"
                    }, 
                    "name": "Veterans Affairs Medical Center - Lexington"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "MBCCOP - LSU Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48109-0752"
                    }, 
                    "name": "University of Michigan Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Barbara Ann Karmanos Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201-1932"
                    }, 
                    "name": "Veterans Affairs Medical Center - Detroit"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64128"
                    }, 
                    "name": "Veterans Affairs Medical Center - Kansas City"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45219"
                    }, 
                    "name": "Barrett Cancer Center, The University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45220-2288"
                    }, 
                    "name": "Veterans Affairs Medical Center - Cincinnati"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78284"
                    }, 
                    "name": "University of Texas Health Science Center at San Antonio"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78284"
                    }, 
                    "name": "Veterans Affairs Medical Center - San Antonio (Murphy)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84132"
                    }, 
                    "name": "Huntsman Cancer Institute"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Single Arm, Phase II Study to Determine the Safety and Efficacy of 4-HPRN-(4-Hydroxyphenyl) Retinamide for Treating Oral Intraepithelial Neoplasia", 
        "overall_official": {
            "affiliation": "Barbara Ann Karmanos Cancer Institute", 
            "last_name": "Omer Kucuk, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2000", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003223"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Southwest Oncology Group", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Southwest Oncology Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 1997", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "July 2012", 
        "why_stopped": "Closed due to poor accrual."
    }, 
    "geocoordinates": {
        "Albert B. Chandler Medical Center, University of Kentucky": "38.041 -84.504", 
        "Arizona Cancer Center": "32.222 -110.926", 
        "Barbara Ann Karmanos Cancer Institute": "42.331 -83.046", 
        "Barrett Cancer Center, The University Hospital": "39.103 -84.512", 
        "Huntsman Cancer Institute": "40.761 -111.891", 
        "MBCCOP - LSU Medical Center": "29.951 -90.072", 
        "University of Kansas Medical Center": "39.114 -94.627", 
        "University of Michigan Comprehensive Cancer Center": "42.281 -83.743", 
        "University of Texas Health Science Center at San Antonio": "29.424 -98.494", 
        "Veterans Affairs Medical Center - Cincinnati": "39.103 -84.512", 
        "Veterans Affairs Medical Center - Detroit": "42.331 -83.046", 
        "Veterans Affairs Medical Center - Kansas City": "39.1 -94.579", 
        "Veterans Affairs Medical Center - Lexington": "38.041 -84.504", 
        "Veterans Affairs Medical Center - San Antonio (Murphy)": "29.424 -98.494", 
        "Veterans Affairs Medical Center - Tucson": "32.222 -110.926"
    }
}